Which ETFs hold AstraZeneca PLC (AZN)?
British-Swedish drugmaker focused on cancer, heart, lung and rare disease medicines.
39 Australian ETFs hold AstraZeneca PLC, a Health Care company from United Kingdom. F100 has the biggest weighting at 8.19%. Across these funds, Australian ETF investors own about $528m of AstraZeneca PLC.
The ETFs with the most AstraZeneca PLC
All 39 ETFs that hold AstraZeneca PLC, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell AstraZeneca PLC.
Common questions
Which ETF has the most AstraZeneca PLC?
F100 (Betashares FTSE 100 ETF) has the highest weighting, with 8.19% of the fund in AstraZeneca PLC.
What is the cheapest ETF that holds AstraZeneca PLC?
Of the ETFs where AstraZeneca PLC is at least 1% of the fund, EXUS has the lowest fee at 0.14% a year, with 1.19% in AstraZeneca PLC.
How much AstraZeneca PLC do I own with $10,000 in VGS?
About $27. VGS is the largest ETF that holds AstraZeneca PLC, and AstraZeneca PLC makes up 0.27% of it.
How many Australian ETFs hold AstraZeneca PLC?
39 ETFs listed on the ASX or TMX Australia hold AstraZeneca PLC, based on issuers' published holdings.